XML 102 R84.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details Narrative) (10-K) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 10, 2018
Jan. 04, 2018
May 31, 2017
Mar. 30, 2018
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares     67   232,151 8,990 67
Before Reverse Split [Member] | Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares     1,000   3,445,266   1,000
NIS [Member]              
Monthly consultation fee   $ 40,000          
CardioSert Ltd [Member]              
Initial payment $ 250,000 $ 50,000          
Buy back amount per patent   $ 1.00          
CardioSert Ltd [Member] | Minimum [Member]              
Investments   $ 2,000,000          
Subsequent Event [Member]              
Buy back amount per patent   $ 1.00          
Conversion of stock into shares       101,063      
Subsequent Event [Member] | Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares       1,500      
Subsequent Event [Member] | Before Reverse Split [Member]              
Conversion of stock into shares       1,500,000      
Subsequent Event [Member] | NIS [Member]              
Monthly consultation fee   $ 40,000,000          
Subsequent Event [Member] | Minimum [Member]              
Investments   $ 2,000,000          
Subsequent Event [Member] | CardioSert Ltd [Member]              
Patent description   Closing of the acquisition in April 2018, CardioSert's issued U.S. patent and three patent applications pending worldwide were added to Microbot's patent portfolio and Microbot now has a patent portfolio of 29 issued/allowed patents and 19 patent applications pending worldwide.          
Initial payment   $ 50,000